Diagnosis of dystonic syndromes-a new eight-question approach

Nature Reviews Neurology

Volumn 8, Issue 5, 2012, Pages 275-283

  Bertram, Kelly L ^a   Williams, David R ^b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; LEVODOPA; NEUROLEPTIC AGENT;

BLEPHAROSPASM; BRAIN CALCIFICATION; CERVICAL DYSTONIA; DOPA RESPONSIVE DYSTONIA; DYSTONIA; EPSILON SARCOGLYCAN GENE; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GTP CYCLOHYDROLASE 1 GENE; HEMIDYSTONIA; HUMAN; METABOLIC DISORDER; MYOCLONUS; NEUROACANTHOCYTOSIS; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OROBULBAR DYSTONIA; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PARKINSONISM; PRIMARY TORSIONAL DYSTONIA; PRIORITY JOURNAL; REVIEW; THAP1 GENE; TOR1A GENE; WILSON DISEASE; WRITER'S CRAMP;

AGE OF ONSET; BRAIN; DIHYDROXYPHENYLALANINE; DYSTONIC DISORDERS; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; METABOLIC DISEASES; NEUROACANTHOCYTOSIS;

EID: 84862786100     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.39     Document Type: Review

References (89)

1. Fahn, S. The varied clinical expressions of dystonia. Neurol. Clin. 2, 541-554 (1984).
2. Albanese, A. & Lalli, S. Is this dystonia? Mov. Disord. 24, 1725-1731 (2009).
3. Schneider, S. A. & Bhatia, K. P. Secondary dystonia-clinical clues and syndromic associations. Eur. J. Neurol. 17, 52-57 (2010).
4. Kanovsky, P. Dystonia: a disorder of motor programming or motor execution? Mov. Disord. 17, 1143-1147 (2002). (Pubitemid 36041327)
5. Grunewald, R. A., Yoneda, Y., Shipman, J. M. & Sagar, H. J. Idiopathic focal dystonia: a disorder of muscle spindle afferent processing? Brain 120, 2179-2185 (1997). (Pubitemid 28014594)
6. Frasson, E. et al. Somatosensory disinhibition in dystonia. Mov. Disord. 16, 674-682 (2001). (Pubitemid 36040847)
7. Rona, S., Berardelli, A., Vacca, L., Inghilleri, M. & Manfredi, M. Alterations of motor cortical inhibition in patients with dystonia. Mov. Disord. 13, 118-124 (1998). (Pubitemid 28029862)
8. Kaji, R. & Murase, N. Sensory function of basal ganglia. Mov. Disord. 16, 593-594 (2001). (Pubitemid 36040837)
9. Hallett, M. Is dystonia a sensory disorder? Ann. Neurol. 38, 139-140 (1995).
10. Tinazzi, M., Squintani, G. & Berardelli, A. Does neurophysiological testing provide the information we need to improve the clinical management of primary dystonia? Clin. Neurophysiol. 120, 1424-1432 (2009).
11. Nemeth, A. H. The genetics of primary dystonias and related disorders. Brain 125, 695-721 (2002). (Pubitemid 34279768)
12. Albanese, A. et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur. J. Neurol. 13, 433-444 (2006). (Pubitemid 43823355)
13. Defazio, G., Abbruzzese, G., Livrea, P. & Berardelli, A. Epidemiology of primary dystonia. Lancet Neurol. 3, 673-678 (2004). (Pubitemid 39370637)
14. rd. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov. Disord. 3, 188-194 (1988).
15. Asgeirsson, H., Jakobsson, F., Hjaltason, H., Jonsdottir, H. & Sveinbjornsdottir, S. Prevalence study of primary dystonia in Iceland. Mov. Disord. 21, 293-298 (2006).
16. A prevalence study of primary dystonia in eight European countries. J. Neurol. 247, 787-792 (2000).
17. Ferraz, H. B. & Andrade, L. A. Symptomatic dystonia: clinical profile of 46 Brazilian patients. Can. J. Neurol. Sci. 19, 504-507 (1992).
18. Wenning, G. K. et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol. 4, 815-820 (2005). (Pubitemid 41619436)
19. Kiriakakis, V., Bhatia, K. P., Quinn, N. P. & Marsden, C. D. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 121, 2053-2066 (1998). (Pubitemid 28497904)
20. Geyer, H. L. & Bressman, S. B. The diagnosis of dystonia. Lancet Neurol. 5, 780-790 (2006). (Pubitemid 44205514)
21. Jankovic, J., Tsui, J. & Bergeron, C. Prevalence of cervical dystonia and spasmodic torticollis in the United States general population. Parkinsonism Relat. Disord. 13, 411-416 (2007). (Pubitemid 47454719)
22. Bressman, S. B. Dystonia update. Clin. Neuropharmacol. 23, 239-251 (2000). (Pubitemid 32014473)
23. Elia, A. E., Lalli, S. & Albanese, A. Differential diagnosis of dystonia. Eur. J. Neurol. 17, 1-8 (2010).
24. Deuschl, G., Bain, P. & Brin, M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov. Disord. 13, 2-23 (1998). (Pubitemid 28517753)
25. Gupta, A. & Lang, A. E. Psychogenic movement disorders. Curr. Opin. Neurol. 22, 430-436 (2009).
26. Chan, J., Brin, M. F. & Fahn, S. Idiopathic cervical dystonia: clinical characteristics. Mov. Disord. 6, 119-126 (1991).
27. Martino, D. et al. The phenomenology of the geste antagoniste in primary blepharospasm and cervical dystonia. Mov. Disord. 25, 407-412 (2010).
28. Greene, P. E. & Bressman, S. Exteroceptive and interoceptive stimuli in dystonia. Mov. Disord. 13, 549-551 (1998). (Pubitemid 28221513)
29. Lalli, S. & Albanese, A. The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov. Disord. 25, 1619-1626 (2010).
30. Garcia-Cazorla, A. et al. Inborn errors of metabolism and motor disturbances in children. J. Inherit. Metab. Dis. 32, 618-629 (2009).
31. van Rootselaar, A. F., van Westrum, S. S., Velis, D. N. & Tijssen, M. A. The paroxysmal dyskinesias. Pract. Neurol. 9, 102-109 (2009).
32. O'Riordan, S. et al. Age at onset as a factor in determining the phenotype of primary torsion dystonia. Neurology 63, 1423-1426 (2004). (Pubitemid 39426275)
33. Schwarz, C. S. & Bressman, S. B. Genetics and treatment of dystonia. Neurol. Clin. 27, 697-718, vi (2009).
34. Bressman, S. B. et al. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann. Neurol. 26, 612-620 (1989).
35. Valente, E. M. et al. The role of DYT1 in primary torsion dystonia in Europe. Brain 121, 2335-2339 (1998).
36. Trender-Gerhard, I. et al. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J. Neurol. Neurosurg. Psychiatry 80, 839-845 (2009).
37. Asmus, F. & Gasser, T. Dystonia-plus syndromes. Eur. J. Neurol. 17, 37-45 (2010).
38. Furukawa, Y. et al. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology 53, 1032-1041 (1999). (Pubitemid 29442120)
39. Schiller, A., Wevers, R. A., Steenbergen, G. C., Blau, N. & Jung, H. H. Long-term course of l-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology 63, 1524-1526 (2004). (Pubitemid 39426298)
40. Schneider, S. A. et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 67, 940-943 (2006). (Pubitemid 44454582)
41. Narbona, J., Obeso, J. A., Tunon, T., Martinez-Lage, J. M. & Marsden, C. D. Hemi-dystonia secondary to localised basal ganglia tumour. J. Neurol. Neurosurg. Psychiatry 47, 704-709 (1984). (Pubitemid 14075414)
42. Marsden, C. D., Obeso, J. A., Zarranz, J. J. & Lang, A. E. The anatomical basis of symptomatic hemidystonia. Brain 108, 463-483 (1985). (Pubitemid 15064805)
43. Perlmutter, J. S. & Raichle, M. E. Pure hemidystonia with basal ganglion abnormalities on positron emission tomography. Ann. Neurol. 15, 228-233 (1984). (Pubitemid 14164736)
44. Pettigrew, L. C. & Jankovic, J. Hemidystonia: a report of 22 patients and a review of the literature. J. Neurol. Neurosurg. Psychiatry 48, 650-657 (1985). (Pubitemid 15026240)
45. Heiman, G. A. et al. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology 63, 631-637 (2004). (Pubitemid 39100817)
46. Ghilardi, M. F. et al. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann. Neurol. 54, 102-109 (2003).
47. Bressman, S. B. et al. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol. 8, 441-446 (2009).
48. Houlden, H. et al. THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology 74, 846-850 (2010).
49. Muller, U. The monogenic primary dystonias. Brain 132, 2005-2025 (2009).
50. Schneider, S. A., Bhatia, K. P. & Hardy, J. Complicated recessive dystonia parkinsonism syndromes. Mov. Disord. 24, 490-499 (2009).
51. Kinugawa, K. et al. Myoclonus-dystonia: an update. Mov. Disord. 24, 479-489 (2009).
52. Hedrich, K. et al. Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology 62, 1229-1231 (2004). (Pubitemid 38456531)
53. Muller, B. et al. Evidence that paternal expression of the ε-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am. J. Hum. Genet. 71, 1303-1311 (2002). (Pubitemid 36015885)
54. Muthane, U. et al. Clinical features of adult GM1 gangliosidosis: report of three Indian patients and review of 40 cases. Mov. Disord. 19, 1334-1341 (2004). (Pubitemid 39534553)
55. Krystkowiak, P. et al. Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms. J. Neurol. Neurosurg. Psychiatry 65, 703-708 (1998). (Pubitemid 28486649)
56. Kostic, V. S., Stojanovic-Svetel, M. & Kacar, A. Symptomatic dystonias associated with structural brain lesions: report of 16 cases. Can. J. Neurol. Sci. 23, 53-56 (1996). (Pubitemid 26075688)
57. Kim, J. S. et al. Focal hand dystonia secondary to Basal Ganglia germinoma. J. Clin. Neurol. 3, 150-153 (2007).
58. Lee, M. S. & Marsden, C. D. Movement disorders following lesions of the thalamus or subthalamic region. Mov. Disord. 9, 493-507 (1994). (Pubitemid 24275065)
59. Cho, C. & Samkoff, L. M. A lesion of the anterior thalamus producing dystonic tremor of the hand. Arch. Neurol. 57, 1353-1355 (2000).
60. Tuschl, K. et al. Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia-A new metabolic disorder. J. Inherit. Metab. Dis. 31, 151-163 (2008).
61. Chang, L. W. The neurotoxicology and pathology of organomercury, organolead, and organotin. J. Toxicol. Sci. 15 (Suppl. 1), 125-151 (1990).
62. Forstl, H., Krumm, B., Eden, S. & Kohlmeyer, K. Neurological disorders in 166 patients with basal ganglia calcification: a statistical evaluation. J. Neurol. 239, 36-38 (1992).
63. Geschwind, D. H., Loginov, M. & Stern, J. M. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am. J. Hum. Genet. 65, 764-772 (1999). (Pubitemid 30468722)
64. Mancini, F. et al. Secondary cervical dystonia in iatrogenic hypoparathyroidism associated with extensive brain calcifications. Funct. Neurol. 21, 165-166 (2006).
65. Hayflick, S. J. et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N. Engl. J. Med. 348, 33-40 (2003). (Pubitemid 36026344)
66. Gregory, A., Polster, B. J. & Hayflick, S. J. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J. Med. Genet. 46, 73-80 (2009).
67. Hayflick, S. J., Hartman, M., Coryell, J., Gitschier, J. & Rowley, H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am. J. Neuroradiol. 27, 1230-1233 (2006). (Pubitemid 44897631)
68. McNeill, A. et al. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 70, 1614-1619 (2008). (Pubitemid 351620317)
69. Chinnery, P. F. et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 130, 110-119 (2007). (Pubitemid 46026227)
70. Morgan, N. V. et al. PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat. Genet. 38, 752-754 (2006). (Pubitemid 43980594)
71. Takeuchi, Y. et al. A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J. Neurol. Neurosurg. Psychiatry 72, 543-545 (2002).
72. McNeill, A., Pandolfo, M., Kuhn, J., Shang, H. & Miyajima, H. The neurological presentation of ceruloplasmin gene mutations. Eur. Neurol. 60, 200-205 (2008).
73. Demarquay, G. et al. Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov. Disord. 15, 1204-1209 (2000).
74. Prashanth, L. K., Taly, A. B., Sinha, S., Arunodaya, G. R. & Swamy, H. S. Wilson's disease: diagnostic errors and clinical implications. J. Neurol. Neurosurg. Psychiatry 75, 907-909 (2004). (Pubitemid 38658520)
75. Walshe, J. M. & Yealland, M. Wilson's disease: the problem of delayed diagnosis. J. Neurol. Neurosurg. Psychiatry 55, 692-696 (1992).
76. Ala, A., Borjigin, J., Rochwarger, A. & Schilsky, M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 41, 668-670 (2005). (Pubitemid 40289516)
77. Liebeskind, D. S., Wong, S. & Hamilton, R. H. Faces of the giant panda and her cub: MRI correlates of Wilson's disease. J. Neurol. Neurosurg. Psychiatry 74, 682 (2003).
78. Tan, E. K. & Chan, L. L. Movement disorders associated with hyperthyroidism: expanding the phenotype. Mov. Disord. 21, 1054-1055 (2006).
79. Kempster, P. A., Brenton, D. P., Gale, A. N. & Stern, G. M. Dystonia in homocystinuria. J. Neurol. Neurosurg. Psychiatry 51, 859-862 (1988).
80. Burlina, A. P., Zara, G., Hoffmann, G. F., Zschocke, J. & Burlina, A. B. Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options. J. Inherit Metab. Dis. 27, 911-915 (2004). (Pubitemid 39433627)
81. Torres, R. J. & Puig, J. G. Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome. Orphanet J. Rare Dis. 2, 48 (2007).
82. Kolker, S. et al. Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J. Inherit. Metab. Dis. 30, 5-22 (2007). (Pubitemid 46140220)
83. Testai, F. D. & Gorelick, P. B. Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders. Arch. Neurol. 67, 148-153.
84. Walker, R. H. et al. Neurologic phenotypes associated with acanthocytosis. Neurology 68, 92-98 (2007). (Pubitemid 46071891)
85. Hardie, R. J. et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 114, 13-49 (1991).
86. Danek, A. & Walker, R. H. Neuroacanthocytosis. Curr. Opin. Neurol. 18, 386-392 (2005). (Pubitemid 41104800)
87. Lee, J. H., Lee, S. M. & Baik, S. K. Demonstration of striatopallidal iron deposition in chorea-acanthocytosis by susceptibility-weighted imaging. J. Neurol. 258, 321-322 (2010)
88. Stevenson, V. L. & Hardie, R. J. Acanthocytosis and neurological disorders. J. Neurol. 248, 87-94 (2001). (Pubitemid 32245417)
89. Danek, A. et al. Neuroacanthocytosis: new developments in a neglected group of dementing disorders. J. Neurol. Sci. 229-230, 171-186 (2005). (Pubitemid 40341582)